News Blog - Colorado Gynecologic Oncology Specialists

FDA Approves First Biosimilar to Neulasta to Help Reduce the Risk of Infection During Cancer Treatment

The U.S. Food and Drug Administration today approved Fulphila (pegfilgrastim-jmdb) as the first biosimilar to Neulasta (pegfilgrastim) to decrease the chance of infection as suggested by febrile neutropenia (fever, often with other signs of infection, associated with an abnormally low number of infection-fighting white blood cells), in patients with non-myeloid (non-bone marrow) cancer who are receiving myelosuppressive chemotherapy that has a clinically significant incidence of febrile neutropenia.

Details

July Newsletter 2018

The Colorado Center for Gynecologic Oncology is excited to share our July Newsletter providing patients with new information, upcoming events and inspiring stories. This month’s Feature Article, “44 Ways to Make the Day of Someone with Cancer” was written by Dr. Elana Miller, physician and cancer survivor. Based on her personal experience, she has compiled…

Details

44 Ways to Make the Day of Someone With Cancer

Make your friend’s life easier by anticipating his or her needs and giving tangible, much-needed support. Here is a list of the top favors people did for me that made my day (and made my life much easier!) after my cancer diagnosis – Elana Miller, MD.

Details

Multi-epitope T-cell Vaccine Shows Promise in Ovarian, Breast Cancer

Clinicians in the not-too-distant future may have something new to offer women with breast cancer and ovarian cancer in whom initial therapy fails to yield a response.

Details

Obesity May Make Women More Vulnerable to a Host of Cancers

The LA Times reports, compared to women of normal weight, those with obesity are 24% more likely to develop one of a handful of cancers linked to the condition, and their chances of developing cancers of the kidney or endometrium were around twice as high as those of normal-weight women, new research has found.

Details